Louis W. Sullivan

Sits on 2 boards. Last updated September 27, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.

3 years ยท Since 2023
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 9, 2026 United Therapeutics Corporation Option exercise +650 โ€” โ€”
Dec 22, 2025 United Therapeutics Corporation Option exercise +3,230 $183.98 $594,255
Dec 22, 2025 United Therapeutics Corporation Option exercise +2,720 $229.81 $625,083
Dec 22, 2025 United Therapeutics Corporation Open-market sale โˆ’1,087 $511.22 $555,696
Dec 22, 2025 United Therapeutics Corporation Open-market sale โˆ’4,863 $512.34 $2,491,509
Jul 25, 2025 United Therapeutics Corporation Option exercise +590 โ€” โ€”
Apr 30, 2025 Emergent BioSolutions Inc. Grant or award +34,403 โ€” โ€”
Dec 19, 2024 United Therapeutics Corporation Gift โˆ’1,851 โ€” โ€”
Dec 18, 2024 United Therapeutics Corporation Option exercise +15,000 $175.43 $2,631,450
Dec 18, 2024 United Therapeutics Corporation Open-market sale โˆ’1,121 $366.11 $410,409
Dec 18, 2024 United Therapeutics Corporation Open-market sale โˆ’600 $366.97 $220,182
Dec 18, 2024 United Therapeutics Corporation Open-market sale โˆ’1,307 $368.50 $481,630
Dec 18, 2024 United Therapeutics Corporation Open-market sale โˆ’2,100 $369.32 $775,572
Dec 18, 2024 United Therapeutics Corporation Open-market sale โˆ’1,400 $370.30 $518,420
Dec 18, 2024 United Therapeutics Corporation Open-market sale โˆ’1,501 $373.12 $560,053

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.